These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9829415)

  • 21. Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.
    Jahnke K; Kraemer DF; Knight KR; Fortin D; Bell S; Doolittle ND; Muldoon LL; Neuwelt EA
    Cancer; 2008 Feb; 112(3):581-8. PubMed ID: 18072268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain.
    Liu R; Martuza RL; Rabkin SD
    Gene Ther; 2005 Apr; 12(8):647-54. PubMed ID: 15647762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rat model of blood-brain barrier disruption to allow targeted neurovascular therapeutics.
    Martin JA; Maris AS; Ehtesham M; Singer RJ
    J Vis Exp; 2012 Nov; (69):e50019. PubMed ID: 23222697
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery.
    Neuwelt EA; Maravilla KR; Frenkel EP; Rapaport SI; Hill SA; Barnett PA
    J Clin Invest; 1979 Aug; 64(2):684-8. PubMed ID: 457877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osmotic blood-brain barrier disruption: a new means of increasing chemotherapeutic agent delivery.
    Neuwelt EA; Frenkel EP; Diehl JT; Maravilla KR; Vu LH; Clark WK; Rapoport SI; Barnett PA; Hill SA; Lewis SE; Ehle AL; Beyer CW; Moore RJ
    Trans Am Neurol Assoc; 1979; 104():256-60. PubMed ID: 121949
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modification.
    Neuwelt EA; Pagel M; Barnett P; Glassberg M; Frenkel EP
    Cancer Res; 1981 Nov; 41(11 Pt 1):4466-70. PubMed ID: 6796261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
    Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
    Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A blood-brain barrier disruption model eliminating the hemodynamic effect of ketamine.
    Fortin D; Adams R; Gallez A
    Can J Neurol Sci; 2004 May; 31(2):248-53. PubMed ID: 15198452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Osmotic blood-brain barrier disruption in the posterior fossa of the dog.
    Neuwelt EA; Glasberg M; Diehl J; Frenkel EP; Barnett P
    J Neurosurg; 1981 Nov; 55(5):742-8. PubMed ID: 6796658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mannitol opening of the blood-brain barrier: regional variation in the permeability of sucrose, but not 86Rb+ or albumin.
    Brown RC; Egleton RD; Davis TP
    Brain Res; 2004 Jul; 1014(1-2):221-7. PubMed ID: 15213006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodal investigations of trans-endothelial cell trafficking under condition of disrupted blood-brain barrier integrity.
    Marchi N; Teng Q; Nguyen MT; Franic L; Desai NK; Masaryk T; Rasmussen P; Trasciatti S; Janigro D
    BMC Neurosci; 2010 Mar; 11():34. PubMed ID: 20214812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies.
    Neuwelt EA; Glasberg M; Frenkel E; Barnett P
    Ann Neurol; 1983 Sep; 14(3):316-24. PubMed ID: 6195955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiographic quantitation of reversible blood-brain barrier disruption in vivo.
    Drayer BP; Schmeckel DE; Hedlund LW; Lischko MM; Sage MR; Heinz ER; Dubois PJ; Goulding PL
    Radiology; 1982 Apr; 143(1):85-9. PubMed ID: 6801727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intracarotid hyperosmolar mannitol in triethyl tin (TET)-induced rat brain edema--preservation of blood-brain barrier (BBB) in TET edema.
    Inoue T; Nagara H; Kondo A; Fukui M; Tateishi J
    Brain Res; 1987 Jun; 414(2):309-13. PubMed ID: 3113663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperosmotic blood-brain barrier disruption in brains of rats with an intracerebrally transplanted RG-C6 tumor.
    Inoue T; Fukui M; Nishio S; Kitamura K; Nagara H
    J Neurosurg; 1987 Feb; 66(2):256-63. PubMed ID: 3100731
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is intra-arterial chemotherapy useful in high-grade gliomas?
    Basso U; Lonardi S; Brandes AA
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):507-19. PubMed ID: 12382519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of enhanced computerized tomography to evaluate osmotic blood-brain barrier disruption.
    Neuwelt EA; Maravilla KR; Frenkel EP; Barnett P; Hill S; Moore RJ
    Neurosurgery; 1980 Jan; 6(1):49-56. PubMed ID: 6153461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pial microvascular responses to transient bilateral common carotid artery occlusion: effects of hypertonic glycerol.
    Lapi D; Marchiafava PL; Colantuoni A
    J Vasc Res; 2008; 45(2):89-102. PubMed ID: 17934320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.